Tickerplace logo

Tickerplace

Cardiol Therapeutics Inc. logo

CRDLCardiol Therapeutics Inc.

CRDL Stock Price, Valuation & Chart | Cardiol Therapeutics Inc.

Compare
$1.100-0.05 (-4.35%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic
OverviewFinancialsDividendsRatios

CRDL Historical price chart

CRDL Key Stats

Market Capitalization132.73M
PE Ratio-4.38
EPS-0.25
Trading Volume586.23K
Today's High/Low1.14/1.09
Dividend Yield0.00
52 Week High/Low2.34/0.88
Shares Outstanding120.66M
CRDL Financial Statement
CRDL Analyst ratings
CRDL Analysis & performance metrics

CRDL Company profile

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment…

CRDL Management team

Management
Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBACFO
Chief Financial Officer, Corporate Secretary & Director
Andrew Warwick Hamer M.D.
Chief Medical Officer and Head of Research & Development
John A. Geddes BSCPT, MBA
Vice President of Corporate Development
Bernard Lim B.Sc.COO
Chief Operating Officer
Trevor Burns
Investor Relations
David G. Elsley MBACEO
President, Chief Executive Officer & Director
Total 6 executives

CRDL Frequently asked questions

What is Cardiol Therapeutics Inc. (CRDL) Stock Price?

Current stock price of Cardiol Therapeutics Inc. (CRDL) stock is $1.100. The stock price is -4.35% lower in the session. The intraday range can be seen from this page. Volume of Cardiol Therapeutics Inc. (CRDL) stock is 586.23K.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Cardiol Therapeutics Inc. (CRDL) stock price going up or down today?

The stock price of Cardiol Therapeutics Inc. (CRDL) can change with earnings, company news, and overall market sentiment. Cardiol Therapeutics Inc. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Cardiol Therapeutics Inc. stock expensive at its current price?

Whether Cardiol Therapeutics Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CRDL on this page is -4.38. EPS on this page is -0.25. Compare those figures with peers and growth expectations before deciding if the current Cardiol Therapeutics Inc. price is justified.

How has the stock price of Cardiol Therapeutics Inc. (CRDL) performed historically?

Historical performance for Cardiol Therapeutics Inc. (CRDL) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CRDL reacted to past earnings and market events.

Should I buy Cardiol Therapeutics Inc. (CRDL) stock, at this price?

Buying Cardiol Therapeutics Inc. (CRDL) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.